KOCAA
KYNB

Knights of Columbus Asset Advisors’s Kyntra Bio KYNB Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,201
Closed -$1.04M – 315
2021
Q1 		$1.04M Sell
1,201
-10
-0.8% -$10.6K 0.1% 241
2020
Q4 		$1.12M Sell
1,211
-2
-0.2% -$2.1K 0.12% 243
2020
Q3 		$1.25M Sell
1,213
-180
-13% -$194K 0.15% 214
2020
Q2 		$1.41M Buy
1,393
+221
+19% +$205K 0.17% 189
2020
Q1 		$1.02M Sell
1,172
-114
-9% -$113K 0.13% 238
2019
Q4 		$1.38M Buy
+1,286
New +$1.31M 0.12% 285

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Knights of Columbus Asset Advisors's KYNB Position: Q2 2021 in Review

Knights of Columbus Asset Advisors sold out of Kyntra Bio (KYNB) in Q2 2021, closing a stake of 1,201 shares — an estimated $1.04M sold.

Knights of Columbus Asset Advisors first reported a position in KYNB in Q4 2019 and held it in 6 quarters. The position peaked at $1.41M in Q2 2020. 174 funds tracked by Wall St. Rank hold KYNB as of Q2 2021.

  • Knights of Columbus Asset Advisors reported no remaining Kyntra Bio position as of Q2 2021 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 1,201 Kyntra Bio shares in Q2 2021, an estimated $1.04M.
  • Knights of Columbus Asset Advisors first reported a position in Kyntra Bio in Q4 2019 and held it in 6 quarters.
  • Knights of Columbus Asset Advisors's Kyntra Bio position peaked at $1.41M in Q2 2020.
  • 174 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2021.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.